Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2012
09/20/2012WO2012123823A1 Combination of anti-clusterin oligonucleotide with hsp90 inhibitor for the treatment of prostate cancer
09/20/2012WO2012123820A1 Combination of anti-clusterin oligonucleotide with androgen receptor antagonist for the treatment of prostate cancer
09/20/2012WO2012123774A1 Glycolytic inhibitor with cytotoxic agent for use in the treatment of a cancer
09/20/2012WO2012123745A1 Pyrrolopyridineamino derivatives as mps1 inhibitors
09/20/2012WO2012123720A1 Colonoscopy - preparation
09/20/2012WO2012123613A1 Inhibitors of s1p receptors for the treatment of calcific aortic stenosis
09/20/2012WO2012123563A1 Benz imidazole derivatives as inhibitors of glutaminyl cyclase
09/20/2012WO2012123561A2 Agent for prophylaxis and treatment of age-associated diseases and disorders and for prolonging life
09/20/2012WO2012123522A1 6,5-heterocyclic propargylic alcohol compounds and uses therefor
09/20/2012WO2012123515A1 An ophthalmic composition
09/20/2012WO2012123506A1 Montelukast intermediate camphorsulfonic salt
09/20/2012WO2012123493A2 Isoxazolidine derivatives
09/20/2012WO2012123491A1 Use of type a2 proanthocyanidins in gastroprotected form for the treatment of acute cystitis induced by fimbriated bacterial forms e
09/20/2012WO2012123482A2 Isoxazolidine derivatives
09/20/2012WO2012123471A1 Thiazole and thiophene compounds
09/20/2012WO2012123470A1 Imidazo pyrazines
09/20/2012WO2012123468A1 New azaspirodecanone compounds
09/20/2012WO2012123466A1 Use of a sprayable composition comprising ambroxol
09/20/2012WO2012123449A1 N- cyclopropyl - n- piperidinylbenzamides as gpr119 modulators
09/20/2012WO2012123432A1 Sec-hydroxycyclohexyl derivatives as hsl inhibitors for the treatment diabetes
09/20/2012WO2012123406A1 Novel use of imidazotriazinones
09/20/2012WO2012123385A1 Polyacrylamide hydrogel for use in the treatment and/or prevention of joint swelling and/or bone oedema in a mammal suffering from arthritis
09/20/2012WO2012123383A2 Buccodental hygiene and/or care composition
09/20/2012WO2012123358A1 4r,5r-enantiomer of 2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with nootropic activity
09/20/2012WO2012123353A1 Novel use of benzofuranylsulfonates
09/20/2012WO2012123325A1 NEW CRYSTAL FORMS OF THE SALT OF TRANS-5-CHLORO-2-METHYL-2,3,3A,12b-TETRAHYDRO-1H-DIBENZO[2,3:6,7]OXEPINO[4,5-c]PYRROLE WITH MALEIC ACID
09/20/2012WO2012123312A1 Pyrido[3,4-b]pyrazine derivatives as syk inhibitors
09/20/2012WO2012123311A1 Pyridinyl- and pyrazinyl -methyloxy - aryl derivatives useful as inhibitors of spleen tyrosine kinase (syk)
09/20/2012WO2012123298A1 Antiviral compounds
09/20/2012WO2012123129A1 Solid state crystalline forms of 4-(2-ethyl-5-fluoro-2,3-dihydro-1h-inden-2-yl)-1h-imidazole
09/20/2012WO2012123076A1 Ferrocene-based compounds and their use as ros regulating prodrugs
09/20/2012WO2012122969A1 Substituted diphenyl derivatives
09/20/2012WO2012122921A1 Salt form of hydroxyphenylalanine kinase inhibitor
09/20/2012WO2012122891A1 Oxime-containing amino derivative, pharmaceutical composition, preparation method and use thereof
09/20/2012WO2012122865A2 Pharmaceutically acceptable salt of (e)-n-[4-[[3-chloro-4-(2-pyridylmethoxy)phenyl]amino]-3-cyano-7-ethoxy-6-quinolyl]-3-[(2r)-1-methylpyrrolidin-2-yl]prop-2-enamide, preparation method therefor, and medical use thereof
09/20/2012WO2012122805A1 Medicine for treating ischemic brain injury and its sequelae and preparation method thereof
09/20/2012WO2012122716A1 Tetracyclic xanthene derivatives and methods of use thereof for treatment of viral diseases
09/20/2012WO2012122707A1 Quaternary ammonium salt compounds, preparation method, pharmaceutical composition and use thereof
09/20/2012WO2012122645A1 Methods of treating cancer by inhibition of dna repair proteins
09/20/2012WO2012122640A1 Compositions, diagnostic methods using epithelial extracellular matrix proteins
09/20/2012WO2012103524A3 Inhibitors of mtor kinasa as anti- viral agents
09/20/2012WO2012103523A3 Novel modulators of development of adipocyte and cancer cells
09/20/2012WO2012103186A3 Androgen composition for treating an opthalmic condition
09/20/2012WO2012103015A3 Extended-release beta agonist/steroid transdermal patches and methods for using the same
09/20/2012WO2012101011A3 New aryl-benzocycloalkyl amide derivatives
09/20/2012WO2012097173A3 Substituted benzoazepines as toll-like receptor modulators
09/20/2012WO2012093971A3 Effervescent compositions comprising amlodipine
09/20/2012WO2012092339A3 The design of hydrolytically releasable prodrugs for sustained release nanoparticle formulations
09/20/2012WO2012089828A3 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
09/20/2012WO2012085284A3 High drug load pharmaceutical formulations comprising dronedarone and its pharmaceutically acceptable salts
09/20/2012WO2012082862A3 Androgen receptor inhibitors and methods of use thereof
09/20/2012WO2012082436A3 Modulators of histone methyltransferase, and methods of use thereof
09/20/2012WO2012076985A8 Granzyme b inhibitor compositions, methods and uses for promoting wound healing
09/20/2012WO2012075500A3 7-deazapurine modulators of histone methyltransferase, and methods of use thereof
09/20/2012WO2012075257A3 Compositions for oral and nasal hygiene
09/20/2012WO2012072977A8 Formulations comprising methylthioninium chloride
09/20/2012WO2012060790A3 Water dispersible cefpodoxime proxetil formulations
09/20/2012WO2012050611A3 Aptamers to glycoprotein vi
09/20/2012WO2012033703A8 Continuous photolytic process for the preparation of vitamin d related substances
09/20/2012WO2012031941A3 2-(R²-THIO)-10-[3-(4-R1-PIPERAZIN-1-YL)PROPYL]-10H-PHENOTHIAZINE FOR TREATING A β-AMYLOIDOPATHY OR AN ALPHA-SYNUCLEOPATHY, AND METHOD FOR THE DIAGNOSIS OR PREDIAGNOSIS THEREOF
09/20/2012WO2011005295A8 Modulators of the sphingosine-1-phosphate (s1p) receptor useful for the treatment of disorders related thereto
09/20/2012US20120240247 Jnk3 modulators and methods of use
09/20/2012US20120240245 Methods and compositions for detecting and treating retinal diseases
09/20/2012US20120239007 Implantable Devices and Methods for Treatment of Pain by Delivery of Fentanyl and Fentanyl Congeners
09/20/2012US20120238940 Cyclooxygenase inhibitor and calcium channel antagonist compositions and methods for use in urological procedures
09/20/2012US20120238938 Method and apparatus for the delivery of photo-chemical (cross-linking) treatment to corneal tissue
09/20/2012US20120238937 Method of treating keloids or hypertrophic scars using antisense compounds targeting connective tissue growth factor (ctgf)
09/20/2012US20120238755 Salts of prodrugs of piperazine and substituted piperidine antiviral agents
09/20/2012US20120238747 Transfection reagents
09/20/2012US20120238639 Pharmaceutical composition comprising propofol
09/20/2012US20120238637 Isolated Extract of Walnuts, Method For Its Obtention And Its Use
09/20/2012US20120238636 Rasagiline orally disintegrating compositions
09/20/2012US20120238634 Interleukin-1 and tumor necrosis factor-alpha modulators; syntheses of such modulators and methods of using such modulators
09/20/2012US20120238633 Hypotensive lipid-containing biodegradable intraocular implants and related methods
09/20/2012US20120238632 Modulators of retinol-retinol binding protein (rbp)-transthyretin (ttr) complex formation
09/20/2012US20120238631 Compositions comprising cyclohexylamines and aminoadamantanes
09/20/2012US20120238630 Compositions comprising nonsteroidal anti - inflammatory drugs
09/20/2012US20120238629 Addition compounds of guanidinoacetic acid
09/20/2012US20120238628 Dihydronaphthalene and naphthalene derivatives as n-formyl peptide receptor like-1 (fprl-1) receptor modulators
09/20/2012US20120238627 N-acetyl-l-cysteine for the treatment of endometriosis
09/20/2012US20120238626 Methods and compositions for promoting the respiratory development of an infant
09/20/2012US20120238625 Biologically active oils
09/20/2012US20120238624 Formulations for the treatment of pain
09/20/2012US20120238623 Inflammation and Autoimmune Disorder Treatment using RARa Selective Agonists
09/20/2012US20120238622 Iron (iii) citrate, substantially free of beta-iron hydroxide oxide
09/20/2012US20120238621 Oligomer-Calcimimetic Conjugates and Related Compounds
09/20/2012US20120238620 TRYPTOPHANYL-tRNA SYNTHETASE-DERIVED POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS
09/20/2012US20120238619 Micro-rna for the regulation of cardiac apoptosis and contractile function
09/20/2012US20120238618 Pharmaceutical Composition Comprising Anti-miRNA Antisense Oligonucleotides
09/20/2012US20120238617 Microrna expression signature in peripheral blood of patients affected by hepatocarcinoma or hepatic cirrhosis and uses thereof
09/20/2012US20120238616 Methods and compositions for treating sleep-related breathing disorders
09/20/2012US20120238615 Alpha adrenergic receptor modulators
09/20/2012US20120238614 Anticonvulsant combination therapy
09/20/2012US20120238613 Sec-hydroxycyclohexyl derivatives
09/20/2012US20120238612 Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof
09/20/2012US20120238611 Dual-acting benzoimidazole antihypertensive agents
09/20/2012US20120238610 Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression
09/20/2012US20120238609 Methods for Treating COPD
09/20/2012US20120238608 Angiotensin ii receptor antagonists
09/20/2012US20120238607 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
1 ... 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 ... 7860